Germany passes law on stem cell research
This article was originally published in Clinica
The decision by the German lower house (Bundestag) last week to allow the restricted import of embryonic stem cells for research purposes has been welcomed by the biotech industry. The move means that MPs have now voted into law the proposals debated in January by a majority of 360 for to 190 compared with 340 for to 265 against during the previous debate (see Clinica No 994, p 5). Three proposed amendments to the law, aimed at either introducing stricter or more relaxed regulations, were defeated.